Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Careteq Ltd. ( (AU:CTQ) ) has provided an announcement.
Careteq has signed a binding agreement to sell its wholly owned subsidiary Embedded Health Solutions to private investment vehicle Nationwide Investments Holdings for $5 million in cash, subject to standard price adjustments and shareholder approval at a March extraordinary general meeting. The divestment, expected to complete around 20 March 2026, will see Nationwide acquire all EHS assets, intellectual property, key staff, clients and brand, while Careteq retains its existing board and management and redirects proceeds to strengthen its balance sheet, expand its HMR Referrals platform and support its defence of ongoing R&D-related tax disputes with the Australian Taxation Office, following a targeted sale process and due diligence on the buyer’s financial capacity.
The most recent analyst rating on (AU:CTQ) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on Careteq Ltd. stock, see the AU:CTQ Stock Forecast page.
More about Careteq Ltd.
Careteq Limited (ASX: CTQ) is a clinical health technology company that provides innovative medication management and clinical governance solutions, with a focus on residential aged care facilities, home care providers and healthcare professionals. Its offerings include clinical pharmacy services, medication reviews, Quality Use of Medicine programs, staff training on complex medicine classes, and technology platforms and reporting tools designed to improve compliance, benchmarking and workflow efficiency, including its HMR Referrals marketplace for home medication reviews in the home care sector.
Average Trading Volume: 172,906
Technical Sentiment Signal: Sell
Find detailed analytics on CTQ stock on TipRanks’ Stock Analysis page.